Osaic Holdings’s BioCardia, Inc. Warrant BCDAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9,560
| Closed | -$95 | – | 7637 |
|
|
2024
Q2 | $95 | Sell |
9,560
-21,030
| -69% | -$418 | ﹤0.01% | 7250 |
|
|
2024
Q1 | $465 | Hold |
30,590
| – | – | ﹤0.01% | 6838 |
|
|
2023
Q4 | $382 | Hold |
30,590
| – | – | ﹤0.01% | 6933 |
|
|
2023
Q3 | $7.65K | Hold |
30,590
| – | – | ﹤0.01% | 6080 |
|
|
2023
Q2 | $22.9K | Hold |
30,590
| – | – | ﹤0.01% | 5473 |
|
|
2023
Q1 | $25.4K | Hold |
30,590
| – | – | ﹤0.01% | 5429 |
|
|
2022
Q4 | $25K | Hold |
30,590
| – | – | ﹤0.01% | 5432 |
|
|
2022
Q3 | $7K | Hold |
30,590
| – | – | ﹤0.01% | 6231 |
|
|
2022
Q2 | $11K | Sell |
30,590
-22,940
| -43% | -$8.96K | ﹤0.01% | 6046 |
|
|
2022
Q1 | $16K | Hold |
53,530
| – | – | ﹤0.01% | 5857 |
|
|
2021
Q4 | $59K | Hold |
53,530
| – | – | ﹤0.01% | 5028 |
|
|
2021
Q3 | $87K | Hold |
53,530
| – | – | ﹤0.01% | 4653 |
|
|
2021
Q2 | $79K | Hold |
53,530
| – | – | ﹤0.01% | 4684 |
|
|
2021
Q1 | $74K | Sell |
53,530
-8,235
| -13% | -$12.7K | ﹤0.01% | 4582 |
|
|
2020
Q4 | $95K | Hold |
61,765
| – | – | ﹤0.01% | 4088 |
|
|
2020
Q3 | $38K | Buy |
61,765
+1,912
| +3% | +$1.3K | ﹤0.01% | 4516 |
|
|
2020
Q2 | $33K | Sell |
59,853
-3,235
| -5% | -$3.09K | ﹤0.01% | 4480 |
|
|
2020
Q1 | $63K | Buy |
+63,088
| New | +$63.3K | ﹤0.01% | 3812 |
|
Osaic Holdings's BCDAW Position: Q3 2024 in Review
Osaic Holdings sold out of BioCardia, Inc. Warrant (BCDAW) in Q3 2024, closing a stake of 9,560 shares — an estimated $95 sold.
Osaic Holdings first reported a position in BCDAW in Q1 2020 and held it in 18 quarters. The position peaked at $95K in Q4 2020. 0 funds tracked by Wall St. Rank hold BCDAW as of Q3 2024.
- Osaic Holdings reported no remaining BioCardia, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
- Osaic Holdings sold 9,560 BioCardia, Inc. Warrant shares in Q3 2024, an estimated $95.
- Osaic Holdings first reported a position in BioCardia, Inc. Warrant in Q1 2020 and held it in 18 quarters.
- Osaic Holdings's BioCardia, Inc. Warrant position peaked at $95K in Q4 2020.
- 0 funds tracked by Wall St. Rank held BioCardia, Inc. Warrant as of Q3 2024.
Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.